Allergan plc, headquartered in Dublin, Ireland, is a global pharmaceutical company. Allergan has more than 17,000 global employees, with operations in approximately 100 countries and revenues of $15.79 billion. ISHN asked David Eherts, PhD, CIH, Vice President Global EHS, based in Madison, NJ, to explain how the company is implementing the “New View” of safety.
In 2013, Allergan (then Actavis) experienced a devastating accident at one of their sites in India. The proximate cause of the incident was a failure by two employees (both chemical engineers) to utilize a bonding strap between a reaction vessel and an intermediate container while charging a flammable solvent.